111 related articles for article (PubMed ID: 23392273)
1. Cognitive impairment in studies of 5HTTLPR and psychosis in Alzheimer's disease: a systematic review.
Creese B; Ballard C; Jones E
Dement Geriatr Cogn Disord; 2013; 35(3-4):155-64. PubMed ID: 23392273
[TBL] [Abstract][Full Text] [Related]
2. Determining the association of the 5HTTLPR polymorphism with delusions and hallucinations in Lewy body dementias.
Creese B; Ballard C; Aarsland D; Londos E; Sharp S; Jones E
Am J Geriatr Psychiatry; 2014 Jun; 22(6):580-6. PubMed ID: 23582751
[TBL] [Abstract][Full Text] [Related]
3. Lewy Bodies, Vascular Risk Factors, and Subcortical Arteriosclerotic Leukoencephalopathy, but not Alzheimer Pathology, are Associated with Development of Psychosis in Alzheimer's Disease.
Fischer CE; Qian W; Schweizer TA; Millikin CP; Ismail Z; Smith EE; Lix LM; Shelton P; Munoz DG
J Alzheimers Dis; 2016; 50(1):283-95. PubMed ID: 26682680
[TBL] [Abstract][Full Text] [Related]
4. Psychotic symptoms in Alzheimer's disease and 5-HTTLPR polymorphism of the serotonin transporter gene: evidence for an association.
Quaranta D; Bizzarro A; Marra C; Vita MG; Seripa D; Pilotto A; Sebastiani V; Mecocci P; Masullo C
J Alzheimers Dis; 2009; 16(1):173-80. PubMed ID: 19158433
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in the G720/G30 gene locus (DAOA) influences the occurrence of psychotic symptoms in patients with Alzheimer's disease.
Di Maria E; Bonvicini C; Bonomini C; Alberici A; Zanetti O; Gennarelli M
J Alzheimers Dis; 2009; 18(4):953-60. PubMed ID: 20009237
[TBL] [Abstract][Full Text] [Related]
6. Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation.
Holmes C; Smith H; Ganderton R; Arranz M; Collier D; Powell J; Lovestone S
J Neurol Neurosurg Psychiatry; 2001 Dec; 71(6):777-9. PubMed ID: 11723200
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with psychotic symptoms in Alzheimer's disease.
Hirono N; Mori E; Yasuda M; Ikejiri Y; Imamura T; Shimomura T; Ikeda M; Hashimoto M; Yamashita H
J Neurol Neurosurg Psychiatry; 1998 May; 64(5):648-52. PubMed ID: 9598682
[TBL] [Abstract][Full Text] [Related]
8. Psychotic symptoms in Alzheimer's disease are not influenced by polymorphic variation at the dopamine receptor DRD3 gene.
Craig D; Hart DJ; Carson R; McIlroy SP; Passmore AP
Neurosci Lett; 2004 Sep; 368(1):33-6. PubMed ID: 15342129
[TBL] [Abstract][Full Text] [Related]
9. [Psychotic symptoms and Alzheimer's disease].
Alberca R; Gil-Néciga E; Salas D; Pérez JA; Lozano P
Neurologia; 2000 Jan; 15(1):8-14. PubMed ID: 10730061
[TBL] [Abstract][Full Text] [Related]
10. Cognitive and behavioral determinants of psychotic symptoms in Alzheimer's disease.
Quaranta D; Vita MG; Bizzarro A; Masullo C; Piccininni C; Gainotti G; Marra C
Dement Geriatr Cogn Disord; 2015; 39(3-4):194-206. PubMed ID: 25572669
[TBL] [Abstract][Full Text] [Related]
11. Clinical and neurocognitive aspects of hallucinations in Alzheimer's disease.
El Haj M; Roche J; Jardri R; Kapogiannis D; Gallouj K; Antoine P
Neurosci Biobehav Rev; 2017 Dec; 83():713-720. PubMed ID: 28235545
[TBL] [Abstract][Full Text] [Related]
12. The interrelations between psychosis, behavioral disturbance, and depression in Alzheimer disease.
Devanand DP
Alzheimer Dis Assoc Disord; 1999 Nov; 13 Suppl 2():S3-8. PubMed ID: 10622673
[TBL] [Abstract][Full Text] [Related]
13. Quantitative electroencephalographic correlates of psychosis in Alzheimer disease.
Edwards-Lee T; Cook I; Fairbanks L; Leuchter A; Cummings JL
Neuropsychiatry Neuropsychol Behav Neurol; 2000 Jul; 13(3):163-70. PubMed ID: 10910086
[TBL] [Abstract][Full Text] [Related]
14. Association between 5-HT(2A) receptor polymorphism and psychotic symptoms in Alzheimer's disease.
Nacmias B; Tedde A; Forleo P; Piacentini S; Guarnieri BM; Bartoli A; Ortenzi L; Petruzzi C; Serio A; Marcon G; Sorbi S
Biol Psychiatry; 2001 Sep; 50(6):472-5. PubMed ID: 11566166
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the 5HT-2A T102C receptor polymorphism and psychotic symptoms in Alzheimer's disease.
Craig D; Donnelly C; Hart D; Carson R; Passmore P
Am J Med Genet B Neuropsychiatr Genet; 2007 Jan; 144B(1):126-8. PubMed ID: 16967466
[TBL] [Abstract][Full Text] [Related]
16. Cumulative effect of COMT and 5-HTTLPR polymorphisms and their interaction with disease severity and comorbidities on the risk of psychosis in Alzheimer disease.
Borroni B; Grassi M; Agosti C; Archetti S; Costanzi C; Cornali C; Caltagirone C; Caimi L; Di Luca M; Padovani A
Am J Geriatr Psychiatry; 2006 Apr; 14(4):343-51. PubMed ID: 16582043
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003.
Ropacki SA; Jeste DV
Am J Psychiatry; 2005 Nov; 162(11):2022-30. PubMed ID: 16263838
[TBL] [Abstract][Full Text] [Related]
18. Serotonergic system genes in psychosis of Alzheimer dementia: meta-analysis.
Ramanathan S; Glatt SJ
Am J Geriatr Psychiatry; 2009 Oct; 17(10):839-46. PubMed ID: 19910872
[TBL] [Abstract][Full Text] [Related]
19. Serotoninergic polymorphisms (5-HTTLPR and 5-HT2A): association studies with psychosis in Alzheimer disease.
Rocchi A; Micheli D; Ceravolo R; Manca ML; Tognoni G; Siciliano G; Murri L
Genet Test; 2003; 7(4):309-14. PubMed ID: 15000807
[TBL] [Abstract][Full Text] [Related]
20. Psychosis and physical aggression in probable Alzheimer's disease.
Deutsch LH; Bylsma FW; Rovner BW; Steele C; Folstein MF
Am J Psychiatry; 1991 Sep; 148(9):1159-63. PubMed ID: 1882992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
